EMERGENCY:Sudden severe headache, weakness, or seizure in a young adult — brain AVM haemorrhage is a medical emergency —call040-46324365immediately — 24 hours, 7 days— 24/7
Brain Arteriovenous Malformation (AVM): A Tangle of Abnormal Blood Vessels and Why Getting the Treatment Decision Right Matters for Decades
A brain arteriovenous malformation (AVM) is an abnormal tangle of arteries and veins in which blood flows directly from arteries into veins without the normal capillary network between them. This creates high pressure abnormal circulation that can rupture and bleed into the brain causing intracerebral haemorrhage or subarachnoid haemorrhage. AVMs may also cause seizures headaches progressive neurological symptoms or be discovered incidentally during MRI or CT imaging performed for unrelated reasons.
An abnormal tangle of blood vessels arteries connecting directly to veins present from birth
Haemorrhage the primary cause of haemorrhagic stroke in young adults under 40
Surgery Gamma Knife Embolisation
Approximately 2 to 4 percent per year for unruptured AVMs higher after a first bleed
040-46324365 24 hours
Most often young adults typically presents between ages 20 and 40
Microsurgery Gamma Knife radiosurgery Endovascular embolisation Combination treatment Observation
A brain arteriovenous malformation (AVM) is an abnormal tangle of blood vessels present from birth, in which arteries connect directly to veins without the normal capillary network. High-pressure arterial blood flows directly into fragile venous vessels that were never designed to sustain arterial pressure. The primary danger is haemorrhage: AVMs are the most important structural cause of haemorrhagic stroke in young adults (aged 20–40). Annual rupture risk: 2–4% per year for unruptured AVMs; significantly higher after a first bleed. At KIMS Neuroscience Hyderabad, all three AVM treatments — microsurgical resection, Gamma Knife radiosurgery, and endovascular embolisation — are available in a single centre.
- What it is
- Abnormal tangle of arteries and veins from birth. High-pressure blood flows directly from artery to vein. Main risk: brain haemorrhage, especially in young adults aged 20–40.
- Annual bleed risk
- 2–4% per year for unruptured AVM. After first haemorrhage: 6–18% in year one. Over a 25-year-old's lifetime, cumulative risk is substantial.
- All 3 treatments at KIMS
- Surgery (immediate permanent obliteration) · Gamma Knife (no incision, 2–3 year latency, 80–90% obliteration) · Embolisation (adjunctive: reduces size before surgery or radiosurgery).
- The Spetzler-Martin grade
- Grade I–II: small, non-eloquent location — surgery recommended · Grade III: individual assessment · Grade IV–V: radiosurgery or embolisation preferred. Not a formula — a starting point for discussion.
- Gamma Knife advantage
- No open surgery · Particularly valuable for deep, eloquent, or surgically inaccessible AVMs (thalamus, brainstem, basal ganglia) · Available at KIMS.
- AVM-associated aneurysms
- Found in up to 36% of AVMs. A major additional haemorrhage risk. Targeted embolisation of the aneurysm component reduces the highest-risk element even when complete AVM obliteration is not planned.
- Emergency
- AVM haemorrhage: 040-46324365 immediately (24/7) · Planned AVM consultation: 040-44885000
| Fact | Details |
|---|---|
| What it is | Congenital abnormal artery-to-vein connection (no capillaries) · Most important structural cause of haemorrhagic stroke in young adults |
| Presentation | Haemorrhage (~50% of presentations) · Seizures (~25–30%) · Progressive deficits (steal phenomenon) · Incidental discovery |
| Annual bleed risk | 2–4% per year (unruptured) · 6–18% in year 1 after first haemorrhage · Higher with: deep venous drainage · associated aneurysms · smaller nidus size |
| Grading | Spetzler-Martin Grade I–V (size + eloquence + venous drainage) · Grade I–II: surgery · Grade III: individual · Grade IV–V: radiosurgery/embolisation |
| Treatments at KIMS | Microsurgical resection (immediate cure) · Gamma Knife (80–90% obliteration over 2–3 years) · Embolisation (adjunctive) · All three in one centre |
| Gamma Knife | 80–90% obliteration for small/moderate AVMs · 2–3 year latency period · Preferred for deep/eloquent location · Available at KIMS |
| Investigation | MRI + DSA (gold standard for nidus mapping) · fMRI for eloquence mapping · CT angiography in acute setting |
About This Condition
What Is a Brain AVM?
A brain arteriovenous malformation AVM is an abnormal tangle of blood vessels present from birth. In a normal brain blood flows from arteries high pressure vessels carrying blood from the heart through a network of tiny capillaries before entering the low pressure venous system. Capillaries slow the blood down reduce the pressure and allow oxygen to be exchanged with brain tissue.
In an AVM this capillary network never formed properly in the developing foetus. Instead a cluster of abnormal vessels the nidus connects arteries directly to veins bypassing the capillaries entirely. High pressure arterial blood flows at speed directly into the venous system. The vessels in the nidus are abnormal in structure thin walled poorly formed and under arterial pressure they were never designed to sustain.
The primary danger of a brain AVM is haemorrhage. When one of these abnormal vessels ruptures blood bleeds into the brain tissue or into the subarachnoid space. AVMs are the most important structural cause of haemorrhagic stroke in young adults in the 20 to 40 age group in India and worldwide.
Brain AVMs are uncommon vascular lesions that typically present in young adults with spontaneous intracranial haemorrhage seizures or headache. A significant proportion are diagnosed incidentally discovered on brain imaging performed for other reasons without any symptoms from the AVM itself.
At KIMS Neuroscience Secunderabad Hyderabad all three treatment modalities for AVMs are available microsurgical resection Gamma Knife radiosurgery and endovascular embolisation. The KIMS Neuroscience team leads the multidisciplinary AVM treatment team every case is assessed individually and the treatment recommendation is tailored to the specific AVM its location its grade and the patient's age and neurological status.
Book AVM Consultation
Our cerebrovascular and AVM team is available for urgent and elective consultations.
040-46324365International enquiries: neuroscience@kimshospitals.comHow Does an AVM Present? What Are the Symptoms?
Haemorrhage the most dangerous and most common presentation
Approximately 50 percent of AVMs first present with haemorrhage bleeding into the brain caused by rupture of one of the abnormal vessels. This is a medical emergency. Symptoms are sudden a severe headache collapse loss of consciousness one sided weakness speech difficulty or seizure. A young adult who has a stroke like event without the usual stroke risk factors hypertension diabetes atrial fibrillation must be investigated immediately for an AVM or other vascular malformation. In Hyderabad and across India AVM haemorrhage is a critically important diagnosis in any young adult presenting with brain bleeding.
Seizures a common presenting feature
Seizures are the presenting symptom in approximately 25 to 30 percent of AVM patients. The seizures may be focal affecting one limb or one side of the body or generalised tonic clonic. In any young adult with new onset seizures brain MRI with vascular sequences is essential to exclude an AVM or cavernoma as the underlying cause. A seizure without a structural abnormality identified on imaging should not be accepted without vascular imaging at KIMS.
Progressive neurological deficits the steal phenomenon
An AVM creates a low resistance pathway blood flows preferentially through the nidus diverting flow away from surrounding normal brain tissue. This arterial steal can cause progressive neurological symptoms weakness sensory changes or cognitive difficulties that worsen over years even without haemorrhage. When a patient develops progressive focal neurological symptoms without haemorrhage AVM related steal is one of the important diagnostic considerations.
Headache
Some AVMs cause chronic headaches typically on one side sometimes pulsatile from the increased blood flow and turbulence in the vascular malformation. These headaches are non specific and overlap with migraine but in any patient with new or changing headache structural imaging is indicated.
Incidental discovery
An increasing proportion of AVMs are discovered incidentally on MRI scans performed for headaches trauma or other unrelated investigations. An incidental finding of a brain AVM is a significant and often frightening discovery. At KIMS the consultation for an incidentally discovered AVM is structured to give the patient and family a clear calm understanding of what the AVM means what its risks are and what the options are without pressure and without jargon.
Assessing an AVM The Spetzler Martin Grading System
Before any treatment decision the AVM must be comprehensively assessed. The most important clinical tool is the Spetzler Martin grading system a points based system that predicts surgical risk and guides the treatment decision.
Spetzler Martin Grade The Three Factors
| Factor | Score |
|---|---|
| AVM size Small less than 3 cm | 1 |
| AVM size Medium 3 to 6 cm | 2 |
| AVM size Large greater than 6 cm | 3 |
| Location eloquent brain No | 0 |
| Location eloquent brain Yes | 1 |
| Venous drainage superficial only | 0 |
| Venous drainage any deep drainage | 1 |
What Is Eloquent Brain?
Eloquent brain refers to regions with clearly mapped critical functions including the motor and sensory cortex language areas visual cortex thalamus hypothalamus internal capsule brainstem and cerebellar hemispheres. Surgery in eloquent locations carries a higher risk of permanent neurological deficit.
What the Grade Means for Treatment
Grades I to II 1 to 2 points
Low surgical risk. Surgery in experienced hands typically achieves excellent outcomes with low morbidity. Surgery is generally recommended.
Grade III 3 points
Intermediate risk. The treatment decision requires individual assessment. Surgery radiosurgery combined approaches or observation may all be appropriate.
Grades IV to V 4 to 5 points
High surgical risk. Surgery carries significant risk of neurological deficit. Radiosurgery embolisation staged multimodality treatment or observation are typically preferred.
Beyond Spetzler Martin The Complete Assessment at KIMS
The grade is a starting point not a formula. At KIMS every AVM assessment includes DSA digital subtraction angiography the gold standard for mapping the nidus feeding arteries and draining veins in precise detail.
MRI with BOLD functional MRI is used for eloquence mapping identifying the relationship between the AVM and critical functional areas of the brain before treatment planning.
A full neurological assessment and complete imaging package allow The KIMS cerebrovascular team to assess not just the grade but the specific microsurgical radiosurgical or endovascular approach in three dimensional detail.
Treatment
Treatment Options at KIMS
The goal of AVM treatment is complete obliteration permanent elimination of all abnormal vessels so that haemorrhage risk is abolished. Partial treatment is generally not acceptable as a final outcome because a partially treated AVM may still haemorrhage and the pattern of blood flow changes after partial treatment can increase rupture risk in some configurations.
Treatment Option 1 : Microsurgical Resection
Microsurgical removal is the most definitive AVM treatment when feasible. The neurosurgeon opens the skull identifies the AVM under the surgical microscope and meticulously dissects and removes the entire nidus. When complete resection is achieved the AVM is permanently gone and the haemorrhage risk is eliminated immediately.
The advantages of surgery :
Immediate permanent obliteration. No latency period the patient is protected from haemorrhage from the day of surgery. Complete pathological specimen for analysis. For Grade I to II AVMs surgery in expert hands achieves excellent outcomes with very low morbidity.
When surgery is recommended :
Small AVMs in accessible non eloquent cortical locations. Superficially located AVMs. AVMs presenting with haemorrhage where the haematoma requires simultaneous evacuation. Grade I to II and selected Grade III AVMs. Young patients where the decades long haemorrhage risk from an untreated or radiosurgery treated AVM is significant.
At KIMS :
All AVM surgery is performed with intraoperative neuromonitoring continuous monitoring of motor sensory and language pathways throughout the procedure intraoperative ICG fluorescence angiography to confirm complete obliteration before the skull is closed and the Stealth AutoGuide robotic cranial guidance system for trajectory planning.
Treatment Option 2 : Gamma Knife Stereotactic Radiosurgery
Gamma Knife radiosurgery delivers precisely focused beams of radiation from 192 sources converging on the AVM nidus from multiple directions. Each individual beam passes harmlessly through surrounding brain tissue. At the convergence point the nidus the radiation dose is sufficient to cause progressive damage to the vessel walls leading to gradual thrombosis and obliteration of the AVM over 2 to 3 years.
Stereotactic radiosurgery achieves 80 to 90 percent complete obliteration for small to moderate sized AVMs with a 2 to 3 year latency period during which progressive obliteration occurs.
The advantages of radiosurgery :
No open surgery the skull is never opened. No general anaesthetic required for the radiosurgery treatment itself. Particularly valuable for AVMs in deep or eloquent locations where surgical access carries high morbidity risk including the thalamus brainstem basal ganglia and eloquent cortex.
The latency period the critical limitation :
During the 2 to 3 years of progressive obliteration after Gamma Knife the AVM still exists and still carries haemorrhage risk. This is the fundamental limitation of radiosurgery compared to surgery. The patient is not immediately protected. For ruptured AVMs the residual haemorrhage risk during the latency period is a significant consideration.
When Gamma Knife is recommended :
AVMs in deep eloquent or surgically inaccessible locations. Grade III to V AVMs where surgical risk is prohibitive. Small to moderate AVMs typically below 10 cm³ volume. Selected patients who decline open surgery. As a follow up treatment for residual AVM after surgical resection or embolisation.
Gamma Knife radiosurgery is available at KIMS Neuroscience Hyderabad.
Treatment Option 3 Endovascular Embolisation
Endovascular embolisation involves guiding a microcatheter from the femoral artery through the circulation to the AVM feeding arteries and injecting embolic material liquid glue Onyx or n BCA directly into the AVM nidus to block blood flow.
Embolisation alone rarely achieves complete AVM obliteration it is primarily used as an adjunctive therapy.
Pre surgical embolisation :
Reducing AVM blood flow before open surgery making resection safer reducing blood loss during surgery and allowing a more controlled surgical dissection.
Pre radiosurgery embolisation :
Reducing AVM volume before Gamma Knife treatment making a large AVM smaller so that radiosurgery can treat the entire residual nidus within the optimal dose constraints.
Targeted embolisation of high risk features :
AVM associated aneurysms found in up to 36 percent of AVMs are a major contributor to haemorrhage risk. Targeted embolisation of the aneurysm component even without attempting complete nidus obliteration reduces the highest risk element of the AVM configuration providing meaningful haemorrhage risk reduction for AVMs not amenable to complete treatment.
Combination Multimodal Treatment
For complex large or high grade AVMs the best outcomes are achieved with a carefully sequenced combination approach typically embolisation followed by surgery or radiosurgery or staged embolisation and radiosurgery over multiple sessions.
At KIMS the multidisciplinary AVM team neurosurgery neurointerventional radiology and radiation oncology meets to discuss every complex AVM case and develop a treatment sequence tailored to each individual's anatomy and clinical situation.
Observation
For certain AVMs particularly small unruptured incidentally discovered AVMs in specific patient populations careful observation with serial MRI and MRA rather than active treatment may be the appropriate choice. This is particularly considered in older patients patients with significant medical comorbidities and patients whose AVM is located in an area where treatment risk clearly exceeds natural history risk.
The management of unruptured AVMs is an area of active debate in neurovascular surgery. The ARUBA trial suggested medical management may be superior to interventional treatment for unruptured AVMs however this study had significant limitations and its conclusions are contested by leading AVM specialists. At KIMS the ARUBA data is presented honestly in the consultation alongside its limitations so that patients can make fully informed decisions.
The Natural History — What Is the Risk of Not Treating?
Understanding the natural history of an untreated AVM is essential to the treatment decision.
Annual haemorrhage risk
The annual haemorrhage risk for an unruptured AVM is approximately 2–4% per year. This seems modest but compounded over a lifetime, it is substantial. A 25-year-old with an unruptured AVM faces a cumulative lifetime haemorrhage risk that makes treatment a serious consideration.
After a first haemorrhage
Following an initial haemorrhage, the risk of rebleed in the first year is significantly elevated approximately 6–18% in the year after the first bleed. This is one of the most important reasons why AVM treatment is typically recommended more urgently after a ruptured presentation.
Seizures and progressive deficits
Untreated AVMs continue to carry seizure risk and may cause progressive neurological deficits through the steal phenomenon. These are disability risks independent of haemorrhage.
The cumulative lifetime risk
Because AVMs typically present in young adults, the lifetime exposure to annual haemorrhage risk even at 2–4% per year accumulates to meaningful probabilities over 40–50 years of expected lifespan. This is the core argument for treatment in young, healthy patients with accessible AVMs.
Investigation and Diagnosis at KIMS
MRI brain with vascular sequences
The first imaging study for suspected AVM. MRI identifies the location, size, and relationship to surrounding brain structures. Gradient echo (GRE) and susceptibility-weighted imaging (SWI) sequences identify old blood products from previous silent microbleeds, indicating prior minor haemorrhage events. BOLD fMRI maps the relationship of the AVM to eloquent brain areas.
CT angiography
Rapid vascular imaging available in the acute setting — provides good delineation of the nidus and feeding vessels as an initial assessment.
Digital subtraction angiography DSA — the definitive investigation
Four-vessel DSA under local anaesthesia provides the most detailed and dynamic imaging of the AVM mapping feeding arteries, the nidus structure, draining veins, and any associated aneurysms with the temporal resolution to assess flow dynamics. DSA is essential before any treatment decision, particularly before surgery. At KIMS, DSA is performed in the neurointerventional suite by the cerebrovascular team.
Related Conditions
Explore related cerebrovascular conditions frequently associated with vascular malformations, haemorrhagic stroke, aneurysm disease, and complex neurovascular disorders:
FAQs
Frequently Asked Questions
EMERGENCY:AVM haemorrhage emergency — sudden headache, seizure, or weakness in a young adult —call040-46324365immediately — 24 hours, 7 days— 24/7
All three AVM treatments available at KIMS. Surgery, Gamma Knife, and embolisation in one specialist centre.
The KIMS Neuroscience cerebrovascular team provide complete AVM management diagnostic DSA and fMRI mapping, microsurgical resection, Gamma Knife radiosurgery, endovascular embolisation, and combined multimodal approaches. Hyderabad's most experienced vascular malformation centre.
neuroscience@kimshospitals.com